Top Markets
Coin of the day
Arix Bioscience plc Arix Bioscience plc

Arix Bioscience plc

ARIX
Rangering i aksjer #36613
Arix Bioscience plc operates as a venture capital firm, focusing its... Arix Bioscience plc operates as a venture capital firm, focusing its investments across the entire lifecycle of companies, from nascent seed-stage ventures and preclinical or clinical asset development to early, mid, and late-stage growth capital rounds, encompassing both private and public equity. The firm's investment mandate is global, targeting the biotechnology sector and seeking out entities involved in groundbreaking therapeutics, cutting-edge technologies, and broader medical innovations spanning healthcare and life sciences. Employing an evergreen funding model, Arix Bioscience predominantly deploys capital directly from its own balance sheet. It generally prefers to secure a board position within its portfolio companies and strategically exits investments once the peak value has been realized. Established in 2015 and headquartered in London, United Kingdom, the company was previously known as Perceptive Bioscience Investments Limited.
Aksjekurs
$1.93
Sist synkronisert: 2024-02-09
Markedsverdi
$2.50M
Endring (1 dag)
6.72%
Endring (1 år)
0.00%
Land
GB
Handel Arix Bioscience plc (ARIX)

Kategori

Inntekter for Arix Bioscience plc (ARIX)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Arix Bioscience plc er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Arix Bioscience plc fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE